EJNMMI Research

Table 5 Highest absorbed doses (mGy/MBq) of ¹⁸⁸Re-liposome in tumor lesions of patients (n = 12)

From: A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of ¹⁸⁸Re-liposome in patients with metastatic tumors

Tumor site	Absorbed dose (mGy/MBq)
Tumor in bone
Pt. 1	0.28
Pt. 3	0.25
Pt. 4	0.12
Tumor in pelvis
Pt. 2	0.16
Tumor in rectum
Pt. 2	0.14
Tumor in lung
Pt. 3	0.39
Pt. 4	0.29
Pt. 8	0.65
Pt. 9	0.33
Pt. 10	0.21
Pt. 11	0.32
Pt. 13	0.61
Pt. 14	1.04
Tumor in liver
Pt. 3	0.86
Pt. 7	0.86
Pt. 8	0.90
Pt. 12	1.70
Tumor in bladder
Pt. 12	0.16
Tumor in NP
Pt. 14	0.15

Pt. patient

Back to article page